Iovance Biotherapeutics Manufacturing LLC
H‑1B Sponsor Verified
Yes. Iovance Biotherapeutics Manufacturing LLC filed 8 H-1B labor condition applications (LCAs) with the U.S. Department of Labor from 2022–2026, including 2 so far in 2026. The average H-1B salary is $112,550 and the most sponsored role is Cmms Supervisor.
Source: U.S. Department of Labor LCA disclosure data. Most recent filing on record: Feb 20, 2026.
LinkedIn ↗Latest Year Filings
2
In 2026
↗ Filter by year
Total H‑1B Filings
8
Since 2020
↗ View records
Avg Annual Salary
$112,550
All years combined
↗ View chart
Top Role
Cmms Supervisor
↗ Click to filter
Filing trend
H‑1B filings by year for Iovance Biotherapeutics Manufacturing LLC
| Year | LCA filings | Avg salary |
|---|---|---|
| 2026 | 2 | $120,000 |
| 2025 | 1 | $120,000 |
| 2024 | 2 | $115,000 |
| 2023 | 2 | $93,699 |
| 2022 | 1 | $123,000 |
Click a bar to filter records
Yearly filings & average salary · swipe to explore
SponsorStats AI
Summary